Sensei Biotherapeutics is an immuno-oncology company that is dedicated to understanding and selectively interacting with the tumor microenvironment in order to tilt the immune system against cancer. We are leveraging our TMAb™ and ImmunoPhage™ platforms to develop highly selective therapeutics that have the potential to alter the relationship between host immune cells and cancer so that the tumor is recognized and treated as if it were an infection. Our team is comprised of lifelong learners striving for insight at the intersection of immunology, oncology and biology. We are driven to apply our scientific curiosity to the critical needs faced daily by people who are diagnosed with cancer and the physicians who treat them. We stay humble, always follow the data, and believe that our deep knowledge of cancer biology, the tumor microenvironment, and immunology will lead us to effective therapies.
Location: United States
Employees: 11-50
Total raised: $258.5M
Founded date: 1999
Investors 2
| Date | Name | Website |
| - | Future Ven... | future.ven... |
| 26.05.2022 | Catalio Ca... | cataliocap... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 18.02.2026 | - | $200M | - |
| 13.01.2021 | Series B | $30M | Catalio Ca... |
| 07.10.2020 | - | $28.5M | - |
Mentions in press and media 10
| Date | Title | Description |
| 18.02.2026 | Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Solve PI3K Resistance | What You Should Know The Deal: Sensei Biotherapeutics has acquired Faeth Therapeutics in a stock-for-stock transaction. Concurrently, Sensei raised a massive $200M in private placement financing to fuel the combined company. The Asset: The ... |
| 06.03.2024 | Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences | - |
| 25.03.2021 | Sensei Biotherapeutics, Inc. announced that it has received $34.5 million in funding from a group of investors | On March 25, 2021, Sensei Biotherapeutics, Inc. (NasdaqGM:SNSE) closed the transaction. The company has amended the terms of transaction. The company has now raised $34.5 million in the transaction. The company has raised $4.5 million in it... |
| 13.01.2021 | Sensei Biotherapeutics Inks $30M in Series B | ROCKVILLE, MD, Sensei Biotherapeutics announced the closing of a $30M Series B financing co-led by Apeiron Investment Group and new investor Catalio Capital Management. >> Click here for more funding data on Sensei Biotherapeutics ... |
| 12.01.2021 | Daily funding roundup - January 11th, 2021 | Aulos Bioscience has raised $40M; Komodo Health landed $44M; EQRx secured $500M Hello Ralphie: Hello Ralphie is a New York-based veterinary telemedicine company. Hello Ralphie raised $1 million in seed funding from HearstLab and WPMC Fund. ... |
| 12.01.2021 | Steve Jurvetson and Maryanna Saenko on their new fund, SPACs and the great tech exodus | Future Ventures — cofounded by Silicon Valley venture capitalist Steve Jurvetson and Maryanna Saenko, a colleague of Jurvetson at his last firm, DFJ, as well as an investor previously with Airbus Ventures and Khosla Ventures — has closed it... |
| 11.01.2021 | Sensei Biotherapeutics Announces $30 Million Financing | BOSTON & ROCKVILLE, Md.--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc., a clinical-stage cancer immunotherapy company, today announced the successful closing of a $30 million Series B financing. The financing was co-led by existing inve... |
| 11.01.2021 | Sensei Biotherapeutics, Inc. announced that it expects to receive $30 million in funding from a group of investors | Sensei Biotherapeutics, Inc. announced that it will receive funding co-led by existing investor Apeiron Investment Group Ltd. and new investor Catalio Capital Management, LP on January 11, 2021. The transaction also included participation f... |
| 14.10.2020 | Money Moves: Arlington’s BlackBoiler secured $3.2M in new funding | Money Moves is a column where we chart the funding raises of tech companies across the region. Have a tip? Email us at dc@technical.ly. Arlington, Virginia-based contract markup technology provider BlackBoiler announced Wednesday that it ha... |
| 07.10.2020 | Sensei Biotherapeutics Raises $28.5M Financing | Sensei Biotherapeutics, Inc., a Gaithersburg, MD- and Boston, MA-based clinical-stage biopharmaceutical company, completed a $28.5m equity financing. The round was co-led by Cambrian Biopharma and H&S Ventures, along with participation ... |